Align
Align

FDA 21 CFR Part 11

Electronic-records and electronic-signature readiness for FDA-regulated environments in biotech, pharma, and life sciences.

Overview

Compliance built into your systems, not bolted on.

For life-sciences companies, FDA 21 CFR Part 11 governs how electronic records and signatures must be controlled. We help you build the technical controls, audit trails, access management, validation, into the Microsoft systems you already run.

Rather than treating compliance as a separate burden, we engineer it into your environment so you stay inspection-ready as you grow.

What's included

Audit-ready records, built into your systems.

Gap assessment

A clear read on where your systems stand against Part 11 requirements.

Access and identity controls

Role-based access, MFA, and least-privilege aligned to the rule.

Audit trails

Tamper-evident records of who did what, when, across regulated systems.

Electronic signatures

Compliant e-signature workflows where records require them.

Validation support

Documentation and validation to evidence your controls.

Ongoing readiness

Monitoring and review so you stay inspection-ready over time.

From the Insights desk

Reading that goes deeper.

All insights
More in Align

Explore the other ways we help align our clients' businesses.

Stay inspection-ready.

Build FDA 21 CFR Part 11 controls into the systems you already run.